Buzz Stocks: Ford Motor Company, Insys Therapeutics Inc, and Himax Technologies, Inc. (ADR)

Today's stocks to watch in the news include Ford Motor Company (NYSE:F), Insys Therapeutics Inc (NASDAQ:INSY), and Himax Technologies, Inc. (ADR) (NASDAQ:HIMX)

Jul 5, 2016 at 10:26 AM
facebook twitter linkedin

U.S. stocks are down following a post-"Brexit" hot streak. Among equities in focus today are automaker Ford Motor Company (NYSE:F), biotech Insys Therapeutics Inc (NASDAQ:INSY), and semiconductor stock Himax Technologies, Inc. (ADR) (NASDAQ:HIMX).

  • F is down 2.6% at $12.39, erasing Friday's gains that stemmed from the company's solid first-half sales figures. Weighing on the stock are concerns about an auto industry slowdown (subscription required), as well as an investigation into "occupants smelling exhaust odors" inside recent Explorer SUV modelsFord Motor Company is down over 16% year-over-year, and option traders have been especially bearish towards the stock, with F's 50-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE) and NASDAQ OMX PHLX (PHLX) of 0.82 sitting higher than 89% of all other readings from the past year. Analysts seem a bit more upbeat, with five of 13 rating the stock a "buy" or better, and without a single "sell" in sight -- leaving the door open for a round of downgrades to exacerbate selling pressure.
  • INSY is up 20.3% at $16.21, after the Food and Drug Administration (FDA) approved its THC-based drug Syndros, which is used for treating anorexia, nausea, and vomiting associated with conditions such as AIDS and chemotherapy treatment. This is a welcome shot in the arm for the stock, which is still down 53.9% year-over-year, and touched a near-two-year low of $11.45 just last week. There's likely some short sellers kicking rocks, with 25% of the stock's float sold short -- an amount that would take over five weeks of trading, at Insys Therapeutics Inc's average daily volume, to cover.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial


Special Offers from Schaeffer's Trading Partners